Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS).
Peicong GeZihan YinChuming TaoChaofan ZengXiaofan YuShixiong LeiJunsheng LiYuanren ZhaiLong MaQiheng HeChenglong LiuWei LiuBojian ZhangZhiyao ZhengSiqi MouZhikang ZhaoShuang WangWei SunMin GuoShuai ZhengJia ZhangXiaofeng DengXingju LiuXun YeQian ZhangRong WangYan ZhangShaosen ZhangChengjun WangZiwen YangNijia ZhangMingxing WuJian SunYujia ZhouZhiyong ShiYonggang MaJianpo ZhouShaochen YuJiaxi LiJunli LuFaliang GaoWenjing WangYanming ChenXingen ZhuDong ZhangJizong ZhaoPublished in: Chinese neurosurgical journal (2024)
The MOYAOMICS project represents a significant step toward comprehending MMD's molecular underpinnings. This multidisciplinary approach has the potential to revolutionize early diagnosis, patient stratification, and the development of targeted therapies for MMD. The identification of blood-based biomarkers and the integration of multiple omics data are critical for improving the clinical management of MMD and enhancing patient outcomes for this complex disease.